Beneficial effects of phenolic compounds from fruit and vegetables in neurodegenerative diseases

Improving the Health-Promoting Properties of Fruit and Vegetable Products

Volumn , Issue , 2008, Pages 145-181

  Singh, M ^a   Ramassamy, C ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449507223     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845694289.2.145     Document Type: Chapter

References (217)

1. Actis-Goretta L., Ottaviani J.I., Keen C.L., Fraga C.G. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBs Lett 2003, 555:597-600.
2. Aggarwal B.B., Kumar A., Bharti A.C. Related anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003, 23(1A):363-398.
3. Ahmed N., Ahmed U., Thornalley P.J., Hager K., Fleisscher G., Munch G. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. J Neurochem 2005, 92(2):255-263.
4. Alam Z.I., Daniel S.E., Lees A.J., Cairns N., Marsden C.D., Jenner P., Halliwell B. Oxidative DNA damage in the Parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 1997, 69(3):1196-1203.
5. Albensi B.C., Mattson M.P. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 2000, 35(2):151-159.
6. Anderson R.M., Bitterman K.J., Wood J.G., Medvedik O., Sinclair D.A. Nicotinamide and Pnc1 govern lifespan extension by caloric restriction in S. cerevisiae. Nature 2003, 423:182-185.
7. Asensi M., Medina I., Ortega A., Carretero J., Bano, Mcobrador E., Estrela J.M. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 2002, 33(3):387-398.
8. Barja G. Free radicals and aging. Trends Neurosci 2004, 27:595-600.
9. Bastianetto S., Yao Z.X., Papadopoulos V., Quirion R. Neuroprotective effects of green and black teas and their catechin gallate esters against betaamyloid-induced toxicity. Eur J Neurosci 2006, 23(1):55-64.
10. Bates G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 2003, 361:1642-1644.
11. Baum L., Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J Alzheimer's Dis 2004, 6(4):367-377.
12. Baur J.A., Pearson J., Price L., Jamieson A., Lerin C., Kalra A., Prabhu V., Allard S., Lopez-Lluch G., Lewis K., Pistell J., Poosala S., Becker G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein W., Spencer G., Lakatta G., Le Couteur D., Shaw J., Navas P., Puigserver P., Ingram K., De Cabo R., Sinclair A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444(7117):337-342.
13. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay. Anal Biochem 1996, 239(1):70-76.
14. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997, 272:20313-20316.
15. Bhakar A.L., Tannis L.L., Zeindler C., Russo M.P., Jobin, Park D.S. Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci 2002, 22(19):8466-8475.
16. Block E. The chemistry of garlic and onions. Sci Am 1985, 252(3):114-119.
17. Brecht S., Kirchhof R., Chromik A., Willesen M., Nicolaus T., Raivich G., Wessig J., Waetzig V., Goetz N., Claussen M., Pearse D., Kuan C.-Y., Vaudano E., Behrens A., Wagner E., Flavell R.A., Davis R.J., Herdegen T. Specific pathophysiological functions of JNK isoforms in the brain. Eur J Neurosci 2005, 21:363-377.
18. Brot N., Weissbach H. Peptide methionine sulfoxide reductase: biochemistry and physiological role. Biopolymers 2000, 55:288-296.
19. Cadenas E., Sies H. The lag phase. Free Radic Res 1998, 28(6):601-609.
20. Cao G., Alessio H.M., Cutler R.G. Oxygen-radical absorbance capacity assays for antioxidants. J Free Radic Biol Med 1993, 14(3):303-311.
21. Carr A.C., Mccall M.R., Frei B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol 2000, 20(7):1716-1723.
22. Carter B.D., Kaltschmidt C., Kaltschmidt B., Offenhauser N., Bohm-Matthaei R., Baeuerle P.A., Barde Y.A. Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 1996, 272(5261):542-545.
23. Castegna A., Aksenov M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., Markesbery W.R., Butterfield D.A. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 2002, 82(6):1524-1532.
24. Chang L., Jones Y., Ellisman M., Goldstein L., Karin M. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev Cell 2003, 4:521-533.
25. Chartier-Harlin M.C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 1991, 353(6347):844-846.
26. Chauhan N.B. Effect of aged garlic extract on APP processing and tau phosphorylation in Alzheimer's transgenic model Tg2576. J Ethanopharmacol 2006, 108(3):385-394.
27. Checkoway H., Powers K., Weller T.S., Franklin G.M., Longstreth W.T.J.R., Swanson P.D. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002, 155:732-738.
28. Chen L., Lee M.J., Li H., Yang C.S. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos 1997, 25(9):1045-1050.
29. Chen L.F., Fischle W., Verdin E., Greene W.C. Duration of nuclear NFkappaB action regulated by reversible acetylation. Science 2001, 293:1653-1657.
30. Chen C.Y., Jang J.H., Li M.H., Surh Y.J. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Comm 2005, 331(4):993-1000.
31. Chen J., Zhou Y., Mueller-Steiner S., Chen L.F., Kwon H., Yi S., Mucke L., Gan L. SIRT1 protects against microglia-dependent beta amyloid toxicity through inhibiting NF-kappa B signaling. J Biol Chem 2005, 280:40364-40374.
32. Choi Y.T., Jung C.H., Lee S.R., Bae J.H., Baek W.K., Suh M.H., Park J., Park C.W., Suh S.I. The green tea polyphenol (-)-epigallocatechin gallate attenuates betaamyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci 2001, 70:603-614.
33. Christen Y. Oxidative stress and Alzheimer disease. Am J Clini Nutr 2000, 71(2):621S-629S.
34. Chu C., Levinthal D., Kulich S., Chalovich E., Defranco D.B. Oxidative neuronal injury: the dark side of ERK 1/2. Eur J Biochem 2004, 271:2060-2066.
35. Clemens J.A., Stephenson D.T., Dixon E.P., Smalstig E.B., Mincy R.E., Rash K.S., Little S.P. Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. Brain Res Mol Brain Res 1997, 48(2):187-196.
36. Clifford M.N., Copeland E.L., Bloxsidge J.P., Mitchell L.A. Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica 2000, 30(3):317-326.
37. Commenges D., Scotet V., Renaud S., Jacqmin-Gadda H., Barberger-Gateau P., Dartigues J.-F. Intake of flavonoids and risk of dementia. Eur J Epidemiol 2000, 16:357-363.
38. Craft J.M., Watterson D.M., Van Eldik L.J. Human amyloid betainduced neuroinflammation is an early event in neurodegeneration. Glia 2006, 53(5):484-490.
39. Dei R., Takeda A., Niwa H., Li M., Nakagomi Y., Watanabe M., Inagaki T., Washimi Y., Yasuda Y., Horie K., Miyata Sobue T.G. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol (Berlin) 2002, 104:113-122.
40. Delange R.J., Glazer A.N. Phycoerythrin fluorescence-based assay for peroxy radicals: a screen for biologically relevant protective agents. Anal Biochem 1989, 177(2):300-306.
41. Dias A.S., Porawski M., Alonso M., Marroni N., Collado P.S., Gonzalez-Gallego J. Quercetin decreases oxidative stress, NF-{kappa}B activation, and iNOS overexpression in liver of Streptozotocin-induced diabetic rats. J Nutr 2005, 135:2299-2304.
42. Dikalov S.I., Vitek M.P., Mason R.P. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical. J Free Radic Biol Med 2004, 36(3):340-347.
43. Dragland S., Senoo H., Wake K., Holte K., Blomhoff R. Several culinary and medicinal herbs are important sources of dietary antioxidants. J Nutr 2003, 133:1286-1290.
44. Duan W., Zhihong G., Haiyang J., Melvin W., Li X.-J., Mattson M.P. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. PNAS 2003, 100:2911-2916.
45. Duan W., Guo Z., Jiang H., Ladenheim B., Xu X., Cadet J.L., Mattson M.P. Paroxetine retards disease onset and progression in Huntingtin mutant mice. Ann Neurol 2004, 55(4):590-594.
46. Ehrnhoefer D.E., Duennwald M., Markovic P., Wacker J.L., Engemann S., Roark M., Legleiter J., Marsh J.L., Thompson L.M., Lindquist S., Muchowski P.J., Wanker E.E. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Hum Mol Genet 2006, 15(18):2743-2751.
47. Floor E., Wetzel M.G. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J Neurochem 1998, 70(1):268-275.
48. Floyd R.A., Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002, 23:795-807.
49. Freudenthal R., Boccia M.M., Acosta G.B., Blake M.G., Merlo E., Baratti C.M., Romano A. NF-kappaB transcription factor is required for inhibitory avoidance long-term memory in mice. Eur J Neurosci 2005, 21(10):2845-2852.
50. Gabbita S.P., Lovell M.A., Markesbery W.R. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem 1998, 71(5):2034-2040.
51. Gemma C., Mesches M.H., Sepesi B., Choo K., Holmes D.B., Bickford P.C. Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar beta-adrenergic function and increases in proinflammatory cytokines. J Neurosci 2002, 22:6114-6120.
52. Giannakou M.E., Partidge L. The interaction between FOXO and SIRT1: tipping the balance towards cell survival. Trends Cell Biol 2004, 14:408-412.
53. Goyarzu P., Malin D.H., Lau F.C., Taglialatela G., Moon W.D., Jennings R., Moy E., Moy D., Lippold S., Shukitt-Hale B., Joseph J.A. Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci 2004, 7(2):75-83.
54. Graham H.N. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992, 21:334-350.
55. Grilli M., Ribola M., Alberici A., Valerio A., Memo M., Spano P. Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene. J Biol Chem 1995, 270(45):26774-26777.
56. Guo Q., Zhao B., Li M., Shen S., Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochem Biophys Acta 1996, 1304:210-222.
57. Hald A., Lotharius J. Oxidative stress and inflammation in Parkinson's disease: is there a causal link?. Exp Neurol 2005, 193:279-290.
58. Halliwell B., Rafter J., Jenner A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidants or not?. Am J Clin Nutr 2005, 81(suppl):268S-276S.
59. Halvorsen B.L., Holte K., Myhrstad M.C., Barikmo I., Hvattum E., Remberg S.F., Wold A.B., Haffner K., Baugerod H., Andersen L.F., Moskaug O., Jacobs J.R., Blomhoff R. A systematic screening of total antioxidants in dietary plants. J Nutr 2002, 132(3):461-471.
60. Han Y.S., Zheng W.H., Bastianetto S., Chabot J.G., Quirion R. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 2004, 141(6):997-1005.
61. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956, 11(3):298-300.
62. Hartman R.E., Shah A., Fagan A.M., Schwetye K.E., Parsadanian M., Schulman R.N., Finn M.B., Holtzman D.M. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis 2006, 24(3):506-515.
63. Hayden M.S., Ghosh S. Signaling to NF-kappaB. J Genes Dev 2004, 18(18):2195-2224.
64. Hayes J.D., Mcmahon M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett 2001, 174(2):103-113.
65. Henley J.M., Barnes J.M., Dev K.K. Cyclothiazide unmasks AMPA-evoked stimulation of [3H]-L-glutamate release from rat hippocampal synaptosomes. Br J Pharmacol 1994, 113(2):339-341.
66. Hetman M., Gozdz A. Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem 2004, 271:2050-2055.
67. Holasek S.S., Wengenack T.M., Kandimalla K.K., Montano C., Gregor D.M., Curran G.L., Poduslo J.F. Activation of the stress activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymtomatic stages of amyotrophic lateral sclerosis in transgenic mice. Brain Res 2005, 1045:185-198.
68. Holmgren A., Johansson C., Berndt C., Lonn M.E., Hudemann C., Lillig C.H. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem Soc Trans 2005, 33(Pt 6):1375-1377.
69. Hoozemans J.J., Veerhuis R., Rozemuller J.M., Eikelenboom P. Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology. Int J Dev Neurosci 2006, 24(2-3):157-165.
70. Howitz K.T., Bittermank J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G. Small molecule activator of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
71. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.P., Ruberg M. Nuclear translocation of NFκB is increased in dopaminergic neurons of patients with Parkinson disease. PNAS USA 1997, 94(14):7531-7536.
72. Ide N., Lau B.H. S-allylcysteine attenuates oxidative stress in endothelial cells. Drug Dev Ind Pharm 1999, 25(5):619-624.
73. Ireson C.R., Orr S., Jones D.J.L., Verschoyle R., Lim C.K. Characterization of metabolites of the chemopreventive agent curcumin in humans and rat hepatocytes and in rat plasma and evaluation of their ability to inhibit phorbol esterinduced prostaglandin E2 production. Cancer Res 2001, 61:1058-1064.
74. Ito Y., Kosuge Y., Sakikubo T., Horie K., Ishikawa N., Obokata N., Yokoyama E., Yamashina K., Yamamoto M., Saito H., Arakawa M., Ishige K. Protective effect of S-allyl-L-cysteine, a garlic compound, on amyloid beta-protein-induced cell death in nerve growth factor-differentiated PC12 cells. Neurosci Res 2003, 46(1):119-125.
75. Jang J.H., Surh Y.J. Protective effect of resveratrol on beta-amyloidinduced oxidative PC12 cell death. Free Radic Biol Med 2003, 34:1100-1110.
76. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemo preventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
77. Joseph J.A., Shukitt-Hale B., Denisova N.A., Bielinski D., Martin A., Mcewen J.J., Bickford P.C. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 1999, 19(18):8114-8121.
78. Joseph J.A., Denisova N.A., Arendash G., Gordon M., Diamond D., Shukitt-Hale B., Morgan D. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 2003, 6(3):153-162.
79. Junn E., Taniguchi H., Jeong B.S., Zhao X., Ichijo H., Mouradian M.M. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase1 activity and cell death. PNAS USA 2005, 102:9691-9696.
80. Kadowaki H., Nishitoh H., Urano F., Sadamitsu C., Matsuzawa A., Takeda K., Mastuni H., Yodoi H., Urano Y., Naganot, Ichijo H. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 2005, 12:19-24.
81. Kaeberlein M., Mcdonagh T., Heltweg B., Hixon J., Westman E.A., Caldwell S.D., Napper A., Curtis R., Distefano P.S., Fields S., Bedalov A., Kennedy B.K. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 2005, 280(17):17038-17045.
82. Kaltschmidt C., Kaltschmidt B., Neumann H., Wekerle H., Baeuerle P.A. Constitutive NF-kappa B activity in neurons. Mol Cell Biol 1994, 14(6):3981-3992.
83. Kaltschmidt B., Uherek M., Volk B., Baeuerle P.A., Kaltschmidt C. Transcription factor NF-kappa is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. PNAS USA 1997, 94(6):2642-2647.
84. Kedar N.P. Can we prevent Parkinson's and Alzheimer's disease?. J Postgrad Med 2003, 49:236-245.
85. Keiss H.P., Dirsch V.M., Hartung T., Haffner T., Trueman L., Auger J., Kahane R., Vollmar A.M. Garlic (Allium sativum L.) modulates cytokine expression in lipopolysaccharide-activated human blood thereby inhibiting NF-kappa activity. J Nutr 2003, 133(7):2171-2175.
86. Kelawala N.S., Ananthanarayan L. Antioxidant activity of selected foodstuffs. Int J Food Sci Nutr 2004, 55(6):511-516.
87. Keller J.N., Hanni K.B., Markesbery W.R. Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech Ageing Dev 2000, 113:61-70.
88. Khoshnan A., Ko J., Watkin E.E., Paige L.A., Reinhart P.H., Patterson P.H. Activation of the IkappaB kinase complex and nuclear factor-kappa B contributes to mutant huntingtin neurotoxicity. J Neurosci 2004, 24(37):7999-8008.
89. Kim D.S., Park S.Y., Kim J.K. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA (1-42) insult. Neurosci Lett 2001, 303:57-61.
90. Kim H.K., Kim M., Kim S., Kim M., Chung J.H. Effects of green tea polyphenol on cognitive and acetylcholinesterase activities. Biosci Biotechnol Biochem 2004, 68(9):1977-1979.
91. Koh S.H., Kim S.H., Kwon H., Park Y., Kim K.S., Song C.W., Kim J., Kim M.H., Yu H.J., Henkel J.S., Jung H.K. Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3. Mol Brain Res 2003, 118:72-81.
92. Koster H., Halsema I., Scholtens E., Knippers M., Mulder G.J. Dosedependent shifts in the sulfation and glucuronidation of phenolic compounds in the rat in vivo and in isolated hepatocytes. The role of saturation of phenolsulfotransferase. Biochem Pharmacol 1981, 30:2569-2575.
93. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219:979-980.
94. Lawson L.D. Garlic: a review of its medicinal effects and indicated active compounds. Phytomedicines of Europe: Chemistry and Biological Activity 1998, 177-209. American Chemical Society, Washington DC. L.D. Lawson, R. Bauer (Eds.).
95. Lee M.J., Maliakal P., Chen L., Meng X., Bondoc F.Y., Prabhu S., Lambert G., Mohr S., Yang C.S. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 2002, 11:1025-1032.
96. Lee B.M., Kwack S.J., Kim H.S. Age-related changes in oxidative DNA damage and benzo(a)pyrene diolepoxide-I (BPDE-I)-DNA adduct levels in human stomach. J Toxicol Env Health A 2005, 68(19):1599-1610.
97. Levites Y., Weinreb O., Maor G., Youdim M.B., Mandel S. Green tea poly-phenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 2001, 78:1073-1082.
98. Levites Y., Amit T., Youdim M.B., Mandel S. Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 2002, 277:30574-30580.
99. Levites Y., Youdim M.B., Maor G., Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. J Biochem Pharmacol 2002, 63(1):21-29.
100. Levites Y., Amit T., Mandel S., Youdim M.B. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J 2003, 17:952-954.
101. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995, 269(5226):973-977.
102. Lilienbaum A., Israël A. From calcium to NF-kappa B signaling pathways in neurons. Mol Cell Biol 2003, 23(8):2680-2698.
103. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001, 21:8370-8377.
104. Lindsay J., Laurin D., Verreault R., Hebert R., Helliwell B., Hill G.B., Mcdowell I. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002, 156:445-453.
105. Loft S., Astrup A., Buemann B., Poulsen H.E. Oxidative DNA damage correlates with oxygen consumption in humans. FASEB J 1994, 8(8):534-537.
106. Longpre F., Garneau P., Christen Y., Ramassamy C. Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. J Free Radic Biol Med 2006, 41(12):1781-1794.
107. Lotito S.B., Fraga C.G. Ascorbate protects (+)-catechin from oxidation both in pure chemical system and human plasma. Biol Res 2000, 33:151-157.
108. Maher P. How protein kinase C activation protects nerve cells from oxidative stress-induced cell death?. J Neurosci 2001, 21(9):2929-2938.
109. Mandemakers W., Morais V.A., De Strooper B. A cell biological perspective on mitochondrial dysfunctions in Parkinson's disease and other neurodegenerative diseases. J Cell Sci 2007, 120(pt10):1707-1716.
110. Marambaud P., Zhao H., Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 2005, 280(45):37377-37382.
111. Marchetti F., De Santi C., Vietri M. Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine. Xenobiotica 2001, 31:841-847.
112. Marier J.F., Vachon P., Gritsas A., Zhang J., Moreau J.P., Ducharme M.P. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 2002, 302(1):369-373.
113. Markesbery W.R. The role of oxidative stress in Alzheimer disease. Arch Neurol 1999, 56(12):1449-1452.
114. Markesbery W.R., Kryscio R.J., Lovell M.A., Morrow J.D. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 2005, 58(5):730-735.
115. Martinez-Florez S., Gutierrez-Fernandez B., Sanchez-Campos S., Gonzalez-Gallego J., Tunon M.J. Quercetin attenuates nuclear factor-kappaB activation and nitric oxide production in interleukin-1beta-activated rat hepatocytes. J Nutr 2005, 135:1359-1365.
116. Matsuzawa A., Saegusa K., Noguchi T., Sadamitsu C., Nishitoh H., Nagai S., Koyasu S., Matsumoto K., Takeda K., Ichijo H. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 2005, 6(6):587-592.
117. Mattson M.P. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromol Med 2003, 3:65-94.
118. Mazza G., Kay C.D., Cottrell T., Holub B.J. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem 2002, 50:7731-7737.
119. Mecocci P., Macgarvey U., Kaufman A.E., Koontz D., Shoffner J.M., Wallace D.C., Beal M.F. Oxidative damage to mitochondrial DNA shows marked agedependent increases in human brain. Ann Neurol 1993, 34:609-616.
120. Meffert M.K., Chang J.M., Wiltgen B.J., Fanselow M.S., Baltimore D. NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 2003, 6(10):1072-1078.
121. Merlo E., Freudenthal R., Maldonado H., Romano A. Activation of the transcription factor NF-kappaB by retrieval is required for long-term memory reconsolidation. Learn Mem 2005, 12(1):23-29.
122. Micheau J., Riedel G. Protein kinases: which one is the memory molecule?. Cell Mol Life Sci 1999, 55:534-548.
123. Migheli A., Piva R., Atzori C., Troost D., Schiffer D. c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1997, 56(12):1314-1322.
124. Miller N.J., Sampson J., Candeias L.P., Bramley P.M., Rice-Evans C.A. Antioxidant activities of carotenes and xanthophylls. FEBS Letts 1996, 384(3):240-242.
125. Mira L., Fernandez M.T., Santos M., Rocha R., Florencio M.H., Jennings K.R. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 2002, 36:1199-1208.
126. Mochizuki H., Imai H., Endo K., Yokomizo K., Murata Y., Hattori N., Mizuno Y. Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Neurosci Lett 1994, 168:251-253.
127. Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., Davis R.J., Shirasaki Y., Greenberg M.E. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci 2001, 21:7551-7560.
128. Motterlini R., Foresti R., Bassi R., Green C.J. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000, 28(8):1303-1312.
129. Moyers S.B., Kumar N.B. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev 2004, 62(5):204-211.
130. Naasani I., Oh-Hashi F., Oh-Hara T. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res 2003, 63:824-830.
131. Nishiyama N., Moriguchi T., Morihara N., Saito H. Ameliorative effect of Sallylcysteine, a major thioallyl constituent in aged garlic extract, on learning deficits in senescence-accelerated mice. J Nutr 2001, 131(3s):1093S-1095S.
132. Nourooz-Zadeh J., Liu E.H., Yhlen B., Anggard E.E., Halliwell B. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J Neurochemi 1999, 72(2):734-740.
133. Numagami Y., Ohnishi S.T. S-Allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia. J Nutr 2001, 131:1100-1105.
134. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 1999, 19(6):1959-1964.
135. Nunomura A., Chiba S., Lippa C.F., Cras P., Kalaria R.N., Takeda A., Honda K., Smith M.A., Perry G. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol Dis 2004, 17(1):108-113.
136. Nunomura A., Honda K., Takeda A., Hirai K., Zhu X., Smith M.A., Perry G. Oxidative damage to RNA in neurodegenerative diseases. J Biomed Biotechnol 2006, 3:82323-82329.
137. Oakley A.E., Collingwood J.F., Dobson J., Love G., Perrott H.R., Edwardson J.A., Elstner M., Morris M. Individual dopaminergic neurons show raised iron levels in Parkinson's disease. Neurology 2007, 68(21):1820-1825.
138. Oestreicher E., Sengstock G.J., Riederer P., Olanow C.W., Dunn A.J., Arendash G.W. Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study. Brain Res 1994, 660:8-18.
139. Ono K., Yamada M. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. J Neurochem 2006, 97:105-115.
140. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J Neurochem 2003, 87:172-181.
141. Orgogozo J.M., Dartigues J.F., Lafont S., Letenneur L., Commenges D., Salamon R., Renaud S., Breteler M.B. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 1997, 153:185-192.
142. Ostrerova-Golts N., Petrucelli L., Hardy J., Lee J.M., Farer M., Wolozin B. The A53T-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci 2000, 20:6048-6054.
143. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18(49):6853-6866.
144. Paik S.R., Shin H.J., Lee J.H. Metal-catalyzed oxidation of α-synuclein in the presence of copper (2) and hydrogen peroxide. Arch Biochem Biophys 2000, 378(2):269-277.
145. Pan T., Fei J., Zhou X., Jankovic J., Le W. Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury. Life Sci 2003, 72:1073-1083.
146. Panov A., Dikalov S., Shalbuyeva N., Georgia Taylor, Sherer T., Greenamyre J.T. Rotenone model of Parkinson's disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem 2005, 280(51):42026-42035.
147. Park S.Y., Kim D.S. Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease. J Nat Prod 2002, 65(9):1227-1231.
148. Peng Q., Buzzard A.R., Lau B.H. Neuroprotective effect of garlic compounds in amyloid beta peptide induced apoptosis in vitro. Med Sci Monit 2002, 8(8):328-337.
149. Pietta P., Simonetti P., Roggi C., Brusamolino A., Pellegrini N., Maccarini L., Testolin G. Dietary flavonoids and oxidative stress. Natural Antioxidants and Food Quality in Atherosclerosis and Cancer Prevention 1996, 249-255. Royal Society of Chemistry, London. J.T. Kumpulainen, J.T. Salonen (Eds.).
150. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993, 342(8873):697-699.
151. Pratico D., Clark C.M., Lee V.M., Trojanowski J.Q., Rokach J., Fitzgerald G.A. Increased 8, 12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann Neurol 2000, 48(5):809-812.
152. Qin Z.H., Chen R.W., Wang Y.M., Nakai M., Chuang D.M., Chase T.N. Nuclear factor kappa B nuclear translocation up regulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J Neurosci 1999, 19(10):4023-4033.
153. Ramassamy C., Averill D., Beffert U., Bastianetto S., Theroux L., Lussier-Cacan S., Cohn J.S., Christen Y., Davignon J., Quirion R., Poirier J. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. J Free Radic Biol Med 1999, 27(5-6):544-553.
154. Ramassamy C., Averill D., Beffert U., Theroux L., Lussier-Cacan S., Cohn J.S., Christen Y., Schoofs A., Davignon J., Poirier J. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. J Neurobiol Dis 2000, 7(1):23-37.
155. Randerath K., Hart R.W., Zhou G.D., Reddy R., Danna T.F., Randerath E. Enhancement of age-related increases in DNA I-compound levels by calorie restriction: comparison of male B-N and F-344 rats. Mutat Res 1993, 295(1):31-46.
156. Rechner A., Kuhnle G., Hu H.L. The metabolism of dietary polyphenols and the relevance to circulating levels of conjugated metabolites. Free Radic Res 2002, 36:1229-1241.
157. Rezai-Zadeh K., Shytle D., Sun N., Mori T., Hou H., Jeanniton D., Ehrhart J., Townsend K., Zeng J., Morgan D., Hardy J., Town T., Tan J. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 2005, 25:8807-8814.
158. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996, 20:933-956.
159. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997, 9:180-186.
160. Russo A., Palumbo M., Aliano C., Lempereur L., Scoto G., Renis M. Red wine micronutrients as protective agents in Alzheimer-like induced insult. Life Sci 2003, 72(21):2369-2379.
161. Sadik C.D., Sies H., Schewe T. Inhibition of 15-lipoxygenases by flavonoids: structure-activity relations and mode of action. Biochem Pharmacol 2003, 65:773-781.
162. Sampson L., Rimm E., Hollman P.C., De Vries J.H., Katan M.B. Flavonol and flavone intakes in US health professionals. J Am Diet Assoc 2002, 102:1414-1420.
163. Sastre J., Pallardo F.V., Vina J. The role of mitochondrial oxidative stress in aging. Free Radic Biol Med 2003, 35:1-8.
164. Savage M.J., Lin Y.G., Ciallella J.R., Flood D.G., Scott R.W. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J Neurosci 2002, 22:3376-3385.
165. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000, 130:2073S-2085S.
166. Scalbert A., Manach C., Morand C., Remesy C., Jimenez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005, 45(4):287-306.
167. Scarmeas N., Stern Y., Tang M.X., Mayeux R., Luchsinger J.A. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006, 59(6):912-921.
168. Scholzke M.N., Potrovita I., Subramaniam S., Prinz S., Schwaninger M. Glutamate activates NF-kappaB through calpain in neurons. Eur J Neurosci 2003, 18(12):3305-3310.
169. Schroeter H., Spencer J.P., Rice-Evans C., Williams R.J. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 2001, 358:547-557.
170. Sellappan S., Akoh C.C., Krewer G. Phenolic compounds and antioxidant capacity of Georgia-grown blueberries and blackberries. J Agric Food Chem 2002, 50:2432-2438.
171. Sheen L.Y., Sheu S.F., Tsai S.J., Meng R.H., Lii C.K. Effect of garlic active principle, diallyl disulfide, on cell viability, lipid peroxidation, glutathione concentration and its related enzyme activities in primary rat hepatocytes. Am J Chin Med 1999, 27(1):95-105.
172. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375(6534):754-760.
173. Shoba G., Joy D., Joseph T., Majeed R., Rajendran, Srinivas P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica 1998, 64:353-356.
174. Shringarpure R., Davies K.J. Protein turnover by the proteasome in aging and disease. Free Radic Biol Med 2002, 32:1084-1089.
175. Shukitt-Hale B., Carey A., Simon L., Mark D.A., Joseph J.A. Effects of Concord grape juice on cognitive and motor deficits in aging. J Nutr 2006, 22(3):295-302.
176. Singletary K.W., Stansbury M.J., Giusti M., Van Breemen R.B., Wallig M., Rimando A. Inhibition of rat mammary tumorigenesis by concord grape juice constituents. J Agric Food Chem 2003, 51(25):7280-7286.
177. Smigrodzki R., Parks J., Parker W.D. High frequency of mitochondrial complex I mutations in Parkinson's disease and aging. Neurobiol Aging 2004, 25:1273-1281.
178. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Marksberry W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease. PNAS USA 1991, 88:10540-10543.
179. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., Kowall N. Oxidative damage in Alzheimer's. Nature 1996, 382:120-121.
180. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time has come? And gone?. Clin Biochem 1997, 30:91-113.
181. Solomon J.M., Pasupuleti R., Xu L. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival after DNA damage. Mol Cell Biol 2006, 26:28-38.
182. Song S., Kim S.Y., Hong Y.M., Jo D.G., Lee J.Y., Shim S.M., Chung C.W., Seo S.J., Yoo Y.J., Koh J.Y., Lee M.C., Yates A.J., Ichijo H., Jung Y.K. Essential role of E2-25K/Hip-2 in mediating amyloidβ neurotoxicity. Mol Cell 2003, 12:553-563.
183. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.M., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. PNAS USA 1993, 90:8098-8102.
184. Sultana R., Boyd-Kimball D., Poon H.F., Cai J., Pierce W.M., Klein J.B., Merchant M., Markesbery W.R., Butterfield D.A. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 2006, 27(11):1564-1576.
185. Sung S., Yang H., Uryu K., Lee E.B., Zhao L., Shineman D., Trojanowski J.Q., Lee V.M., Pratico D. Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. Am J Pathol 2004, 165(6):2197-2206.
186. Sutherland B.A., Shaw O.M., Clarkson A.N., Jackson D.N., Sammut I.A., Appleton I. Neuroprotective effects of (-)-epigallocatechin gallate following hypoxiaischemia-induced brain damage: novel mechanisms of action. FASEB J 2005, 19(2):258-260.
187. Suzuki M., Tabuchi M., Ikeda M., Umegaki K., Tomita T. Protective effects of green tea catechins on cerebral ischemic damage. Med Sci Monit 2004, 10(6):166-174.
188. Sweatt J.D. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 2004, 14:311-317.
189. Swiecilo A., Krawiec Z., Wawryn J., Bartosz G., Bilinski T. Effect of stress on the lifespan of yeast Saccharomyces cerevisiae. Acta Biochim Pol 2000, 47:355-364.
190. Tamagno E., Parola M., Guglielmotto M., Santoro G., Bardini P., Marra L., Tabaton M., Danni O. Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. J Free Radic Biol Med 2003, 35(1):45-58.
191. Temlett J.A., Landsberg J.P., Watt F., Grime G.W. Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis. J Neurochem 1994, 62:134-146.
192. Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., Minowa O., Miyazono K., Noda T., Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2001, 2(3):222-228.
193. Truelsen T., Thudium D., Gronbaek M. Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology 2002, 59:1313-1319.
194. Um M.Y., Choi W.H., Aan J.Y., Kim S.R., Ha T.Y. Protective effect of Polygonum multiflorum Thunb on amyloid beta-peptide 25-35 induced cognitive deficits in mice. J Ethnopharmacol 2006, 104(1-2):144-148.
195. Valerio A., Boroni F., Benarese M., Sarnico I., Ghisi V., Bresciani L.G., Ferrario M., Borsani G., Spano P., Pizzi M. NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production. Eur J Neurosci 2006, 23(7):1711-1720.
196. Van Hoorn D.E.C., Nijveldt R.J., Van Leeuwen P.A.M. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Pharmacol 2002, 451:111-118.
197. Wahlstrom, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol 1978, 43:86-92.
198. Walle T., Hsieh F., Delegge M.H., Oatis Je J.R., Walle U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004, 32(12):1377-1382.
199. Wang R.F., Xie W.D., Zhang Z., Xing D.M., Ding Y., Wang W., Ma C., Du L.J. Bioactive compounds from the seeds of Punica granatum (pomegranate). J Nat Prod 2004, 67(12):2096-2098.
200. Wang Y., Chang C.F., Chou J., Chen H.L., Deng X., Harvey B.K., Cadet J.L., Bickford P.C. Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage. Exp Neurol 2005, 193:75-84.
201. Wang J., Ho L., Zhao Z., Seror I., Humala N., Dickstein D.L., Thiyagarajan M., Percival S.S., Talcott S.T., Pasinetti G.M. Moderate consumption of Cabernet Sauvignon attenuates Aβ neuropathology in a mouse model of Alzheimer's disease. FASEB J 2006, 20:2313-2320.
202. Ward W.F., Qi W., Van Remmen H., Zackert W.E., Roberts L.J., Richardson A. Effects of age and caloric restriction on lipid peroxidation: measurement of oxidative stress by F2-isoprostane levels. J Gerontol A 2005, 60(7):847-851.
203. Whitton P.S. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol 2007, 150(8):963-976.
204. Williams T.I., Lynn B.C., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 2006, 27(8):1094-1099.
205. Wiesner R.J., Zsurka G., Kunz W.S. Mitochondrial DNA damage and the aging process: facts and imaginations. Free Radic Res 2006, 40(12):1284-1294.
206. Wiseman S., Mulder T., Rietveld A. Tea flavonoids: bioavailability in vivo and effects on cell signaling pathways in vitro. Antioxid Redox Signal 2001, 3(6):1009-1021.
207. Wood-Kaczmar A., Gandhi S., Wood N.W. Understanding the molecular causes of Parkinson's disease. Trends Mol Med 2006, 12(11):521-528.
208. Wyttenbach A., Sauvageot O., Carmichael J., Latoud C.D., Arrigo A.P., Rubinsztein D.C. Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Human Mol Genet 2002, 11(9):1137-1151.
209. Xu J., Guo C.J., Yang J.J., Wei J.Y., Li Y.F., Pang W., Jiang Y.G., Cheng S. Intervention of antioxidant system function of aged rats by giving fruit juices with different antioxidant capacities. Zhonghua Yu Fang Yi Xue Za Zhi 2005, 39(2):80-83. (in Chinese).
210. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., Cole G.M. Curcumin inhibits formation of amyloid {beta} oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005, 280:5892-5901.
211. Yazawa K., Kihara T., Shen H., Shimmyo Y., Niidome T., Sugimoto H. Distinct mechanisms underlie distinct polyphenol-induced neuroprotection. FEBS Letts 2006, 580(28-29):6623-6628.
212. Yeh Y.Y., Liu L. Cholesterol-lowering effect of garlic extracts and organosulfur compounds. J Nutr 2001, 131(3s):989S-993S.
213. Yeh S.H., Lin C.H., Lee C.F., Gean P.W. A requirement of nuclear factorkappaB activation in fear-potentiated startle. J Biol Chem 2002, 277(48):46720-46729.
214. Yeung F., Hoberg J.E., Ramsey C.S. Modulation of NF-kappa-dependent transcription and cell survival by SIRT1 deacetylase. EMBO J 2004, 23:2369-2380.
215. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunodetection of 4-hydroxynonenal protein adducts in Parkinson's disease. PNAS 1996, 93(7). 2696-2670.
216. Yoshiike Y., Tanemura K., Murayama O., Akagi T., Murayama M., Sato S., Sun X., Tanaka N., Takashima A. New insights on how metals disrupt amyloid betaaggregation and their effects on amyloid-beta cytotoxicity. J Biol Chem 2001, 276(34):32293-32299.
217. Zuccato C., Ciammola A., Rigamonti D., Leavitt B.R., Goffredo D., Conti L., Macdonald M.E., Friedlander R.M., Silani V., Hayden M.R., Timmuskt, Sipione S., Cattaneo E. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 2001, 293:493-498.